Jørgensen et al. also found that HLA-G expression was regulated partially by DNA methylation since the DNA methyltransferase inhibitor, 5-aza-2’-deoxycytidine, induced HLA-G expression, suggesting the feasibility of manipulating HLA-G expression for immunotherapy in breast cancer (72). The gene discussed is HLA-G; the disease is breast cancer.